A value framework for cancer screening: Advice for high-value care from the American college of physicians

Annals of Internal Medicine

Volumn 162, Issue 10, 2015, Pages 712-717

  Harris, Russell P ^a   Wilt, Timothy J ^b   Qaseem, Amir ^c   Biebelhausen, John ^d   Desai, Sanjay ^d   Feinberg, Lawrence ^d   Horwitch, Carrie A ^d   Humphrey, Linda L ^d   McLean, Robert M ^d   Mir, Tanveer P ^d   Moyer, Darilyn V ^d   Skeff, Kelley M ^d   Tape, Thomas G ^d   Wiese, Jeffrey ^d  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Minneapolis Veterans Affairs Health Care System   (United States)

^c AMERICAN COLLEGE OF PHYSICIANS   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER SCREENING; CONCEPTUAL FRAMEWORK; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SOCIETY; PATIENT CARE; PATIENT HARM; PHYSICIAN; PRIORITY JOURNAL; REVIEW; ADVERSE EFFECTS; ASYMPTOMATIC DISEASE; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECONOMICS; MASS SCREENING; PRACTICE GUIDELINE; RISK ASSESSMENT; UTILIZATION;

ASYMPTOMATIC DISEASES; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; HUMANS; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT;

EID: 84932107112     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-2327     Document Type: Review

References (41)

1. Woolf SH, Harris R. The harms of screening: new attention to an old concern. JAMA. 2012;307:565-6. [PMID: 22318274] doi: 10.1001/jama.2012.100
2. Owens DK, Qaseem A, Chou R, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. High-value, costconscious health care: concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med. 2011; 154:174-80. [PMID: 21282697] doi:10.7326/0003-4819-154-3-201102010-00007
3. Fisher ES, Welch HG. Avoiding the unintended consequences of growth in medical care: how might more be worse? JAMA. 1999; 281:446-53. [PMID: 9952205]
4. Qaseem A, Alguire P, Dallas P, Feinberg LE, Fitzgerald FT, Horwitch C, et al. Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care. Ann Intern Med. 2012;156: 147-9. [PMID: 22250146] doi:10.7326/0003-4819-156-2-201201170-00011
5. Baker DW, Qaseem A, Reynolds PP, Gardner LA, Schneider EC; American College of Physicians Performance Measurement Committee. Design and use of performance measures to decrease lowvalue services and achieve cost-conscious care. Ann Intern Med. 2013;158:55-9. [PMID: 23108285] doi:10.7326/0003-4819-158-1-201301010-00560
6. Snyder L; American College of Physicians Ethics, Professionalism, and Human Rights Committee. American College of Physicians Ethics Manual: sixth edition. Ann Intern Med. 2012;156:73-104. [PMID: 22213573] doi:10.7326/0003-4819-156-1-201201031-00001
7. Wilt TJ, Harris RP, Qaseem A; High Value Care Task Force of the American College of Physicians. Screening for cancer: advice for high-value care from the American College of Physicians. Ann Intern Med. 2015;162:718-25. doi:10.7326/M14-2326
8. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L; U.S. Preventive Services Task Force. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151:727-37. [PMID: 19920273] doi:10.7326/0003-4819-151-10-200911170-00009
9. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: A targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:638-58. [PMID: 18838718] doi:10.7326/0003-4819-149-9-200811040-00245
10. Whitlock EP, Vesco KK, Eder M, Lin JS, Senger CA, Burda BU. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155:687-97. [PMID: 22006930] doi:10.7326/0003-4819-155-10-201111150-00376
11. Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive Services Task Force recommendation. Ann Intern Med. 2013;159:411-20. [PMID: 23897166] doi:10.7326/0003-4819-159-6-201309170-00690
12. Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med. 2013;369:245-54. [PMID: 23863051] doi:10.1056/NEJMoa1301851
13. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011;155:481-92. [PMID: 22007042] doi:10.7326/0003-4819-155-8-201110180-00004
14. Morioka-Douglas N, Hillard PJ. No Papanicolaou tests in women younger than 21 years or after hysterectomy for benign disease. JAMA Intern Med. 2013;173:855-6. [PMID: 23568165] doi:10.1001/jamainternmed.2013.316
15. Robertson DJ, Burke CA, Welch HG, Haile RW, Sandler RS, Greenberg ER, et al. Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med. 2009;151:103-9. [PMID: 19620162] doi:10.7326/0003-4819-151-2-200907210-00007
16. Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, et al; Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151:738-47. [PMID: 19920274] doi:10.7326/0003-4819-151-10-200911170-00010
17. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:659-69. [PMID: 18838717] doi:10.7326/0003-4819-149-9-200811040-00244
18. Kulasingam SL, Havrilesky L, Ghebre R, Myers ER. Screening for cervical cancer: a decision analysis for the U.S. Preventive Services Task Force. AHRQ Publication No. 11-05157-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
19. de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160:311-20. [PMID: 24379002] doi:10.7326/M13-2316
20. Harris R. Overview of screening: where we are and where we may be headed. Epidemiol Rev. 2011;33:1-6. [PMID: 21709142] doi: 10.1093/epirev/mxr006
21. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102:605-13. [PMID: 20413742] doi:10.1093/jnci/djq099
22. Harris R, Sawaya GF, Moyer VA, Calonge N. Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive Services Task Force. Epidemiol Rev. 2011;33:20-35. [PMID: 21666224] doi: 10.1093/epirev/mxr005
23. Harris RP, Sheridan SL, Lewis CL, Barclay C, Vu MB, Kistler CE, et al. The harms of screening: a proposed taxonomy and application to lung cancer screening. JAMA Intern Med. 2014;174:281-5. [PMID: 24322781] doi:10.1001/jamainternmed.2013.12745
24. Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA Intern Med. 2014;174:448-54. [PMID: 24380095] doi:10.1001/jamainternmed.2013.13635
25. Brewer NT, Salz T, Lillie SE. Systematic review: the longterm effects of false-positive mammograms. Ann Intern Med. 2007; 146:502-10. [PMID: 17404352] doi:10.7326/0003-4819-146-7-200704030-00006
26. Brodersen J, Siersma VD. Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med. 2013;11: 106-15. [PMID: 23508596] doi:10.1370/afm.1466
27. Rychetnik L, Carter SM, Abelson J, Thornton H, Barratt A, Entwistle VA, et al. Enhancing citizen engagement in cancer screening through deliberative democracy. J Natl Cancer Inst. 2013;105:380-6. [PMID: 23378639] doi:10.1093/jnci/djs649
28. Korenstein D, Falk R, Howell EA, Bishop T, Keyhani S. Overuse of health care services in the United States: an understudied problem. Arch Intern Med. 2012;172:171-8. [PMID: 22271125] doi:10.1001/archinternmed.2011.772
29. Ransohoff DF, McNaughton Collins M, Fowler FJ. Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback. Am J Med. 2002;113: 663-7. [PMID: 12505117]
30. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291:71-8. [PMID: 14709578]
31. Emanuel EJ, Fuchs VR. The perfect storm of overutilization. JAMA. 2008;299:2789-91. [PMID: 18560006] doi:10.1001/jama.299 .23.2789
32. Moyer VA. What we don't know can hurt our patients: physician innumeracy and overuse of screening tests [Editorial]. Ann Intern Med. 2012;156:392-3. [PMID: 22393136] doi:10.7326/0003-4819-156-5-201203060-00015
33. Sirovich BE, Woloshin S, Schwartz LM. Too little? Too much? Primary care physicians' views on US health care: a brief report. Arch Intern Med. 2011;171:1582-5. [PMID: 21949169] doi:10.1001/archinternmed.2011.437
34. Herndon MB, Schwartz LM, Woloshin S, Anthony D, Gallagher P, Fowler FJ, et al. Older patients perceptions of "unnecessary" tests and referrals: a national survey of Medicare beneficiaries. J Gen Intern Med. 2008;23:1547-54. [PMID: 18592324] doi:10.1007/s11606-008-0626-9
35. Colla CH. Swimming against the current-what might work to reduce low-value care? N Engl J Med. 2014;371:1280-3. [PMID: 25271601] doi:10.1056/NEJMp1404503
36. LeFevre ML. Swimming upstream: doing less in health care is hard: comment on "No Papanicolaou tests in women younger than 21 years or after hysterectomy for benign disease" and "Cervical cancer screening intervals, 2006 to 2009". JAMA Intern Med. 2013;173: 856-8. [PMID: 23568453] doi:10.1001/jamainternmed.2013.535
37. Hoffmann TC, Del Mar C. Patients' expectations of the benefits and harms of treatments, screening, and tests: a systematic review. JAMA Intern Med. 2015;175:274-86. [PMID: 25531451] doi:10 .1001/jamainternmed.2014.6016
38. Gawande AA, Colla CH, Halpern SD, Landon BE. Avoiding lowvalue care. N Engl J Med. 2014;370:e21. [PMID: 24693918] doi: 10.1056/NEJMp1401245
39. Garber AM. A menu without prices [Editorial]. Ann Intern Med. 2008;148:964-6. [PMID: 18483127] doi:10.7326/0003-4819-148-12-200806170-00223
40. Choosing Wisely Web site. Philadelphia: ABIM Foundation; 2015. Accessed at www.choosingwisely.org on 8 January 2015.
41. Caverly TJ, Combs BP, Moriates C, Shah N, Grady D. Too much medicine happens too often: the teachable moment and a call for manuscripts from clinical trainees [Editorial]. JAMA Intern Med. 2014; 174:8-9. [PMID: 24080955] doi:10.1001/jamainternmed.2013.9967